Our open access, online journal, ESMO Open is now listed in Pubmed Central, only 10-months after launch. Learn more about the journal!
There are many good reasons to become an ESMO member. Find out why you should join Europe's leading medical oncology society
ESMO’s flagship scientific journal, Annals of Oncology, publishes editorials, reviews, original articles and letters related to oncology
In this video interview, Giannis Mountzios and Stefan Bielack, Co-Chairs of the ESMO/SIOPE Cancer in Adolescents and Young Adults (AYA) Working Group speak about collaboration and combining expertise for a group of patients that represents a unique constellation, patients who are neither adults nor children, and who deserve the best from both societies.
27 Jul 2017
It is intended for the treatment of adult patients with newly diagnosed AML who are FLT3 mutation-positive
26 Jul 2017
Second cancers are deadlier in patients under age 40 than in older adults
25 Jul 2017
New indication concerns monotherapy in locally-advanced or metastatic urothelial carcinoma in adults who have received prior platinum-containing...
24 Jul 2017
It is intended for the treatment of locally-advanced or metastatic urothelial carcinoma and locally-advanced or metastatic NSCLC
21 Jul 2017
Applications deadline extended until 24 July 2017! Submit it now!
21 Jul 2017
Current supplement provides confirmation of clinical benefit required under accelerated approval and also expands indication
Oxford, United Kingdom
04 Aug
- 06 Aug
2017
Madrid, Spain
08 Sep
- 12 Sep
2017
Zurich, Switzerland
13 Oct
- 14 Oct
2017
Singapore
15 Nov
- 16 Nov
2017
Barcelona, Spain
16 Nov
- 19 Nov
2017
Singapore
17 Nov
- 19 Nov
2017
